Crossmark

Repurposing the yellow fever vaccine for intratumoral immunotherapy

Crossref DOI link: https://doi.org/10.15252/emmm.201910375

Published Online: 2019-11-19

Published Print: 2020-01-09

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Aznar, Maria Angela https://orcid.org/0000-0002-7970-1672
Molina, Carmen

Teijeira, Alvaro

Rodriguez, Inmaculada

Azpilikueta, Arantza

Garasa, Saray

Sanchez‐Paulete, Alfonso R

Cordeiro, Luna

Etxeberria, Iñaki

Alvarez, Maite

Rius‐Rocabert, Sergio

Nistal‐Villan, Estanislao

Berraondo, Pedro

Melero, Ignacio https://orcid.org/0000-0002-1360-348X
Funding

Funding for this research was provided by:

Ministerio de Economía y Competitividad (SAF2014‐52361‐R)

Ministerio de Economía y Competitividad (SAF2017–83267‐C2–1‐R)

Fundación Científica Asociación Española Contra el Cáncer

Cancer Research Institute

Fundación BBVA
License Information

Version of Record valid from 2019-11-19
More Information

Publication History

Received: 2019-01-25

Accepted: 2019-10-24

Published: 2019-11-19